Clinical Trials for Mesothelioma Patients—Electronic Tool to Record Cancer Symptoms: Patient Characteristics
Read about the patient characteristics and prior therapy requirements for a current electronic clinical trial being conducted on patients with advanced cancer or malignant mesothelioma. Please note: this information is provided by Weitz & Luxenberg for informational purposes only. This trial is currently only being conducted in Switzerland.
- Able to understand assessment instrument language
- Able to understand physician communication without difficulty (i.e., due to culture, language, speech)
Prior Concurrent Therapy:
- See Disease Characteristics
- No concurrent participation in another clinical trial
Courtesy of ClinicalTrials.gov, a service of the U.S. National Institutes of Health